Combined effects of temozolomide and the ribonucleotide reductase inhibitors didox and trimidox in malignant brain tumor cells. [electronic resource]
Producer: 20030826Description: 41-6 p. digitalISSN:- 0344-5704
- Antineoplastic Agents, Alkylating -- metabolism
- Benzamidines -- therapeutic use
- Brain Neoplasms -- drug therapy
- Dacarbazine -- analogs & derivatives
- Drug Synergism
- Enzyme Inhibitors -- pharmacology
- Glioma -- drug therapy
- Humans
- Hydroxamic Acids -- therapeutic use
- Ribonucleotide Reductases -- antagonists & inhibitors
- Temozolomide
- Tumor Cells, Cultured -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.